English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
Together for a Cure: Reflecting on 2024 and Looking Ahead
As 2024 comes to a close, we reflect on an extraordinary year for the iCMLf community - one defined by progress, collaboration, and a shared determination to improve outcomes for people living with CML.
Meet the iCMLf at ASH 2024 and at the iCMLf Fourm on Dec 6th
December 2024 - The 66th ASH Annual Meeting kicks off this Saturday with nearly 8,000 abstracts and key CML highlights await.
For those of you attending ASH in person, there will be many opportunities for collaboration and we look forward to meeting you there! If you would like to arrange a meeting with the iCMLf, please reach out at info@cml-foundation.org.
There’s still time to register for the iCMLf Forum at ASH on December 6th that will be chaired by iCMLf Director, Dr Katia Pagnano. This is your chance to connect with global experts and discuss ideas and developments to advance treatment-free remission in CML globally.
Celebrating the Giants in CML - Nominate for the 2025 iCMLf Prizes
November 2024 - Each year, we honour outstanding achievements in CML research and management by recognising exceptional lifetime contributions through the iCMLf Prizes.
Over the past 15 years, 38 extraordinary individuals—scientists, clinicians, and advocates from 14 countries have been recognised for their inspiring leadership, groundbreaking work, and lifelong dedication to improving the lives of people with CML.
We urge you to take part in preserving this proud tradition by nominating exceptional CML leaders who are most deserving of the prestigious iCMLf Prizes in 2025.
Let’s spotlight those who are CML experts and game-changers – visionaries whose work has shaped CML research and treatment globally.
Getting ready for ASH 2024 - Plan your CML Sessions
November 2024 - Only a few weeks to go until the 66th Annual Meeting of the American Society of Hematology (ASH). This year the meeting is held in San Diego, USA, and online from December 7-10th.
With nearly 8,000 abstracts, this largest hematology event of the year is a must-attend for the latest in hematology research, including important updates on CML.
To help you plan your CML meeting schedule, we have compiled a list of sessions on CML for your convenience including oral sessions, posters presentations and a Satellite Symposium on Friday. And… don’t forget the iCMLf Forum on Advancing Treatment Free Remission globally on the 7th December at 12pm. Register here.
Members of the iCMLf team will be on-site, so if you'd like to arrange a meeting, please reach out at info@cml-foundation.org.
We look forward to connecting with you in San Diego.
Learn more...
Personal perspectives on CML from the 2024 iCMLf prize recipients
October 2024 - The recipients of the three 2024 iCMLf Prizes received their medals at the recent ESH-iCMLf 26th John Goldman Conference on CML: Biology and Therapy. During their acceptance speeches they shared insights into their incredible work which has significantly shaped the way we understand and treat CML today.
The keynote presentations of the 2024 prize recipients are now available to view on the iCMLf website, and they reflect the innovation, compassion, and dedication of all three prize winners across CML research, treatment, and patient advocacy.
You can listen to Professor Neil Shah’s personal view on the challenges of treatment resistance, Professor Jeff Lipton exploring the therapeutic goals of CML from the perspectives of both physicians and patients, and Viji Venkatesh share her powerful account of collaborative efforts in CML patient support and community-building.
Highlights from the 2024 ESH-iCMLf 26th Annual John Goldman Conference on CML: Biology and Therapy
The ESH-iCMLf 26th Annual John Goldman Conference on CML: Biology and Therapy, held in Prague, brought together world-leading experts to discuss the latest advancements in the treatment and biology of CML. Jointly organised bythe European School of Haematology (ESH) and the iCMLf , the event featured cutting-edge research presentations, insightful discussions, and collaborative sessions focused on driving innovation in CML management.
